$78.64
Value $131B
MO and SLSN stock compared: price, dividend, valuation and results, from SEC filings.
$78.64
Value $131B
$1.52
Value $107M
Altria (MO) has a market value of $131B and Solesence (SLSN) $107M. Over the last year, with dividends, MO moved +44.7% and SLSN -21.6%. The P/E is 16.2 for MO and 39.0 for SLSN. Dividend yield: MO 5.46%, SLSN none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MO$131B
SLSN$107M
MO is 1,225 times SLSN
Revenue, 12 months
MO$23.5B
SLSN$61M
MO is 386 times SLSN
Net income, 12 months
MO$8.1B
SLSN$2.8M
MO is 2,950 times SLSN
Operating margin
MO47.0%
SLSN6.0%
41.0 points apart
ROIC
MO38.4%
SLSN18.7%
19.7 points apart
P/E
MO16.2
SLSN39.0
SLSN is 2.4 times MO
Dividend yield
MO5.5%
SLSN0.0%
5.5 points apart
5-year return
MO+157.7%
SLSN-60.8%
218.5 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
MO+157.7%
SLSN-60.8%
| Period | MOWith dividends | SLSNWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +44.7%Price +35.5% | -21.6%Price -21.6% |
| 3 years since November 13, 2023 | +146.0%+35.0% a yearPrice +96.6% | +60.0%+17.0% a yearPrice +60.0% |
| 5 years since November 12, 2021 | +157.7%+20.8% a yearPrice +75.1% | -60.8%-17.1% a yearPrice -60.8% |
| 10 years since November 15, 2016 | +153.8%+9.8% a yearPrice +27.2% | +133.8%+8.9% a yearPrice +133.8% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
MOAltriaSLSNSolesence
| Price | $78.64 | $1.52 |
|---|---|---|
| Market value | $131B | $107M |
| Enterprise value (EV) | $153B | $112M |
| P/E | 16.2 | 39.0 |
| P/E, 5-year median | 14.0 | – |
| P/B | – | 6.4 |
| EV/EBIT | 13.8 | 30.5 |
| Free cash flow yield | 6.9% | – |
| Revenue, 12 months | $23.5B | $61M |
|---|---|---|
| Net income, 12 months | $8.1B | $2.8M |
| Free cash flow, 12 months | $9.1B | – |
| Earnings per share, 12 months | $4.85 | $0.04 |
| Revenue growth, year on year | -3.1% | 18.6% |
| Revenue growth a year, past | -2.3%over 5 years | +29.4%over 5 years |
| EPS growth a year, past | +11.4%over 5 years | -7.8%over 5 years |
| Gross margin | 63.3% | 31.7% |
|---|---|---|
| Operating margin | 47.0% | 6.0% |
| Net margin | 34.5% | 4.5% |
| ROIC | 38.4% | 18.7% |
| ROE | – | 19.5% |
| Cash | $2.7B | $1.3M |
|---|---|---|
| Total debt | $24.1B | $14M |
| Net debt / EBITDA | 1.9 | 1.1 |
| Interest cover | 9.4× | – |
| Dividend yield | 5.5% | – |
|---|---|---|
| Dividend per share, 12 months | $4.29 | – |
| Dividend growth a year, past | +4.1%over 5 years | – |
| Buyback yield | 0.8% | – |
| Shareholder yield | 6.2% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Altria ($131B) is about 1,224.6 times Solesence ($107M), at today's prices.
Since November 15, 2016, MO's price moved +27.2% and SLSN's +133.8%. With dividends: MO +153.8% (+9.8% a year), SLSN +133.8% (+8.9% a year). Past returns do not predict future ones.
The dividend yield at today's price is 5.46% for Altria and none for Solesence. Over the last twelve months they paid $4.29 and – per share.
At today's price, the P/E is 16.2 for MO and 39.0 for SLSN. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 34.5% for Altria and 4.5% for Solesence, and the operating margin 47.0% and 6.0%. Revenue was $23.5B and $61M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.